“…5,6 Striatal binding ratio (SBR) in striatum measured by DAT-SPECT has been demonstrated to be associated with motor manifestations, including rigidity, 7,8 resting tremor, 9 and bradykinesia. 8 Apart from its associations with motor symptoms, striatum SBR was also linked to multiple non-motor symptoms, such as RBD, 10 cognitive impairment, 10–13 anxiety, 10 apathy, 14 depression, 15,16 impulse control disorders, 17 sexual dysfunction, 18 urinary dysfunction, 19 cardiovascular dysfunction, 20 gastrointestinal dysfunction, 21 and olfaction loss. 22 Taken together, striatum SBR is an essential indicator of dopaminergic neurodegeneration in PD, which intimately correlated with both motor and non-motor symptoms.…”